VYNE Therapeutics Inc. (VYNE) Live Share Price, Invest From India

VYNE Therapeutics Inc. Stock Performance

as on July 28, 2026 at 2:15 pm IST

Day's Low
Day's High
$23.37
Day's Price Range
$28.40
$28.56
18.17%
Downside
-0.56%
Upside
52 Week's Low
52 Week's High
$14.03
52-Week Price Range
$46.95
$28.56
50.89%
Downside
64.39%
Upside

VYNE Therapeutics Inc. share price movements today

Previous Close: $25.45
Open: $23.37
Volume: 326.8K
Day's Low - High: $23.37 - $28.40
52 Week Low - High: $14.03 - $46.95

VYNE Therapeutics Inc. Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

VYNE Therapeutics Inc. Stock Fundamentals & Key Indicators

Check VYNE Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

0.00%

VYNE Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of VYNE Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
VYNE Therapeutics Inc.	BUY	$-	NA	NA	0.00%	NA
Revolution Medicines Inc.	BUY	$40.9B	539.16%	NA	0.00%	NA
Vertex Pharmaceuticals Inc.	BUY	$122.3B	140.57%	28.66	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$76.0B	32.14%	16.98	29.65%	NA

Analyst Recommendation on VYNE Therapeutics Inc. Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for VYNE Therapeutics Inc.. Average target price of $2

VYNE Therapeutics Inc. Share Price Target

Get share price movements and forecasts by analysts on VYNE Therapeutics Inc..

What analysts predicted

-1328%DOWNSIDE

Target Price

Current Price

$28.56

Analyzed by

9 Analysts

Target

$2.00

VYNE Therapeutics Inc. target price $2, a slight downside of -1328% compared to current price of $28.56. According to 9 analysts rating.

VYNE Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	0	0	0	0	0	0	0	0	0	0
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-6	-6	-9	-12	-12	-8	-5	-7	-4	-3
Net Profit Margin	-8142.11%	-6376.53%	-4750.51%	-10047.11%	-14311.90%	-4262.87%	-8340.58%	-4307.69%	-3720.77%	-4168.60%

VYNE Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	0	4	10	1	20	0	0	0	0	0
Gross Profit	0	4	10	0	19	0	0	0	0	0
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-14	-29	-51	-70	-255	-73	-23	-28	-39	-26
Net Profit Margin	-2087.24%	-634.57%	-483.51%	-4026.51%	-1217.40%	-7876.37%	-4865.83%	-6710.38%	-7950.90%	-4646.14%

Global Institutional Holdings in VYNE Therapeutics Inc.

Funds	Holdings
Shay Capital LLC	4.82%
State Street Corp	0.05%
Northern Trust Corp	0.07%
ADAR1 Capital Management LLC	3.19%
Commonwealth Equity Services Inc	0.05%

See all

Insights on VYNE Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, -7.28M → -3.58M (in $), with an average increase of 42.7% per quarter
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 636.0% return, outperforming this stock by 723.7%
NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 407.9% return, outperforming this stock by 472.8%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 169.0K → 86.0K (in $), with an average decrease of 28.5% per quarter
NEGATIVE IMPACT
Price Dip
In the last 7 days, VYNE stock has moved down by -43.0%

About VYNE Therapeutics Inc.

VYNE Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing differentiated therapies to treat chronic inflammatory and immune-mediated conditions with high unmet need. It is developing VYN202, an oral, small molecule BD2-selective BET inhibitor. VYN202 is an oral, small molecule BD2-selective BET inhibitor that has been designed to achieve potential class-leading potency and selectivity for BD2 vs. BD1. The Company has rights to research, develop and commercialize products containing BET inhibitor compounds for the treatment of any disease, disorder or condition in humans. Utilizing its InhiBET platform and through its preclinical and clinical activities, the Company is evaluating the impact that BET inhibitor compounds have on regulating.

Organisation	VYNE Therapeutics Inc.
E-voting on shares	Click here to vote

FAQs

What is VYNE Therapeutics Inc. share price today?

VYNE Therapeutics Inc. share price today is $28.56 as on July 28, 2026 at 8:45 am IST at the close of the market. VYNE Therapeutics Inc. share today touched a day high of $28.40 and a low of $23.37.

What is the 52 week high and 52 week low for VYNE Therapeutics Inc. share?

VYNE Therapeutics Inc. share touched a 52 week high of $46.95 on July 23, 2026 and a 52 week low of $14.03 on September 9, 2025. VYNE Therapeutics Inc. stock price today i.e. July 28, 2026 at 8:45 am IST is closed at $28.56,which is 39.17% down from its 52 week high and 103.64% up from its 52 week low.

How to invest in VYNE Therapeutics Inc. Stock (VYNE) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for VYNE Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in VYNE Therapeutics Inc. Shares that will get you 0.0525 shares as per VYNE Therapeutics Inc. share price of $28.56 per share as on July 28, 2026 at 8:45 am IST.

What is the minimum amount required to buy VYNE Therapeutics Inc. Stock (VYNE) from India?

Indian investors can start investing in VYNE Therapeutics Inc. (VYNE) shares with as little as ₹95.39 or $1 (as of August 2, 2026 at 8:40 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹953.90 in VYNE Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on August 2, 2026 at 8:40 pm IST). Based on VYNE Therapeutics Inc. share’s latest price of $28.56 as on July 28, 2026 at 8:45 am IST, you will get 0.3501 shares of VYNE Therapeutics Inc.. Learn more about fractional shares .